Autolus Therapeutics plc (AUTL) › Operating Cash FlowAutolus Therapeutics plc (AUTL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$9.85M2017: -$16.36M2018: -$31.54M2019: -$101.48M2020: -$117.76M2021: -$117.86M2022: -$112.31M2023: -$145.59M2024: -$206.27M2025: -$283.57M-$283.57M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$283.57M-37.5%2024-$206.27M-41.7%2023-$145.59M-29.6%2022-$112.31M+4.7%2021-$117.86M-0.1%2020-$117.76M-16.0%2019-$101.48M-221.8%2018-$31.54M-92.8%2017-$16.36M-66.1%2016-$9.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share